ENTITY
Novavax

Novavax (NVAX US)

13
Analysis
Health CareUnited States
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
more
Refresh
Company Presentation10 May 2024 20:30
Company Presentation01 Mar 2024 23:00
Company Presentation28 Feb 2024 21:30
Company Presentation01 Nov 2023 20:00
Company Presentation09 Nov 2023 21:30
x